Literature DB >> 20494894

ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference.

A Davenport1, S D Anker, A Mebazaa, A Palazzuoli, G Vescovo, R Bellomo, P Ponikowski, I Anand, N Aspromonte, S Bagshaw, T Berl, I Bobek, D N Cruz, L Daliento, M Haapio, H Hillege, A House, N Katz, A Maisel, S Mankad, P McCullough, F Ronco, A Shaw, G Sheinfeld, S Soni, N Zamperetti, P Zanco, C Ronco.   

Abstract

Many patients with heart failure have underlying renal dysfunction, and similarly, patients with kidney failure are prone to cardiac failure. This has led to the concept of cardio-renal syndromes, which can be an acute or chronic cardio-renal syndrome, when cardiac failure causes deterioration in renal function, or acute and/or chronic Reno-Cardiac syndrome, when renal dysfunction leads to cardiac failure. Patients who develop these syndromes have increased risk of hospital admission and mortality. Although there are clinical guidelines for managing both heart failure and chronic kidney disease, there are no agreed guidelines for managing patients with cardio-renal and/or Reno-Cardiac syndromes, as these patients have typically been excluded from clinical trials. We have therefore reviewed the currently available published literature to outline a consensus of current best clinical practice for these patients.

Entities:  

Mesh:

Year:  2010        PMID: 20494894     DOI: 10.1093/ndt/gfq252

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

Review 1.  Peritoneal Dialysis for Heart Failure.

Authors:  Harish Puttagunta; Stephen G Holt
Journal:  Perit Dial Int       Date:  2015-11       Impact factor: 1.756

2.  Anticoagulation in chronic kidney disease patients-the practical aspects.

Authors:  Stephen Hughes; Iren Szeki; Michael J Nash; Jecko Thachil
Journal:  Clin Kidney J       Date:  2014-08-02

3.  The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.

Authors:  Piotr Ponikowski; Gerasimos Filippatos; Josep Comin Colet; Ronnie Willenheimer; Kenneth Dickstein; Thomas Lüscher; Giedrius Gaudesius; Barbara von Eisenhart Rothe; Claudio Mori; Nicola Greenlaw; Ian Ford; Iain Macdougall; Stefan D Anker
Journal:  Eur J Heart Fail       Date:  2015-02-11       Impact factor: 15.534

4.  Strategies for preserving residual renal function in peritoneal dialysis patients.

Authors:  Arkom Nongnuch; Montira Assanatham; Kwanpeemai Panorchan; Andrew Davenport
Journal:  Clin Kidney J       Date:  2015-01-13

5.  Prognostic value of estimated plasma volume in patients with chronic systolic heart failure.

Authors:  Yuyao Lin; Yanbo Xue; Jing Liu; Xiqiang Wang; Linyan Wei; Ling Bai; Aiqun Ma
Journal:  J Investig Med       Date:  2020-12-22       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.